Company Monitoring Page for Aurobindo

latest headlines for company on cafepharma

Teva, after Lupin deal, holds another Austedo generic challenger to a 2033 launch
Fierce Pharma
Sun, 06/12/22 - 08:19 pm
Tags:
Teva Pharmaceutical, Austedo, generics, patents, tardive dyskinesia, Aurobindo
J&J takes Aurobindo to court over potential Erleada generic
Endpoints
Tue, 05/31/22 - 11:53 pm
Tags:
JNJ, Aurobindo, legal, generics, Erleada
Aurobindo warned for lax investigations, repeat GMP violations
RAPS.org
Thu, 01/27/22 - 10:46 am
Tags:
regulatory, FDA, Aurobindo, drug manufacturing
While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats
Endpoints
Fri, 12/6/19 - 09:54 am
Tags:
Novartis, FDA, Gilenya, MS, multiple sclerosis, Mylan, Dr Reddy's, Torrent Pharmaceuticals, Aurobindo, generics
Aurobindo is the Latest Company to Recall Ranitidine Medications
BioSpace
Sun, 11/10/19 - 07:50 pm
Tags:
Aurobindo, ranitidine, product recalls
Manufacturing problems persist for Aurobindo, U.S.' second-largest generics producer
Fierce Pharma
Tue, 04/9/19 - 10:18 pm
Tags:
Aurobindo, generics, Novartis, drug manufacturing
UnitedHealthcare, fueled by federal probes, sues generics makers for price fixing
Fierce Pharma
Tue, 01/22/19 - 11:48 am
Tags:
UnitedHealthcare, generics, price fixing, drug pricing, Mylan, Teva Pharmaceuticals, Sandoz, Actavis, Par Pharmaceutical, Sun Pharma, Aurobindo, Taro Pharmaceuticals
Novartis sells parts of Sandoz for $1bn
Pharmaforum
Thu, 09/6/18 - 09:40 am
Tags:
Novartis, Sandoz, M&A, dermatology, Aurobindo
List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape
GoinPharma
Mon, 05/14/18 - 09:32 am
Tags:
Novartis, dermatology, generics, M&A, Aurobindo, Shanghai Fosun Pharmaceutical, Apollo Global Management
Aurobindo bids $1.6B for Novartis' U.S. dermatology generics: report
Fierce Pharma
Mon, 05/7/18 - 10:53 pm
Tags:
Aurobindo, Novartis, Sandoz, M&A, dermatology, India
FDA Approves First Generic Versions of Amgen’s Sensipar
RAPS.org
Thu, 03/8/18 - 07:27 pm
Tags:
FDA, generics, Amgen, Sensipar, Cipla, Aurobindo
Lilly's Strattera faces first wave of generic competition
BioPharma Dive
Fri, 06/2/17 - 11:31 am
Tags:
Eli Lilly, Strattera, generics, ADHD, Apotex, Aurobindo, Glenmark, Teva Pharmaceutical
Golfing, ‘girls night out’ where pharma employees allegedly fixed prices
Stat
Fri, 12/23/16 - 09:59 am
Tags:
generics, Aurobindo, Citron Pharma, Heritage Pharma, Teva, Mayne Pharma, Mylan, drug pricing, price fixing, price collusion
Recent FDA Approvals - Aug 15 2016
CP Wire
Mon, 08/15/16 - 03:50 pm
Tags:
Aurobindo, Merck, FDA, drug approvals, Sun Pharma, Santarus, Keytruda, Boston Scientific, devices, Heron Therapeutics
Aurobindo Said to Enter Fray for $1.5 Billion Teva Portfolio
Bloomberg
Tue, 07/5/16 - 10:29 am
Tags:
Aurobindo, Teva Pharmaceutical, M&A, UK, Ireland, Iceland, India
Actavis to Sell Some European Operations to Aurobindo Pharma
Bloomberg
Sat, 01/18/14 - 11:20 am
Tags:
Actavis, Aurobindo, M&A
Aurobindo Pharma declares 'hidden' income
Times of India, India
Sun, 02/12/12 - 11:25 am
Tags:
Aurobindo
India's Aurobindo Pharma posts 1Q loss
MarketWatch
Sat, 08/6/11 - 01:56 pm
Tags:
Aurobindo, earnings
Aurobindo Pharma Gets USFDA Nod to Market Ramipril Tablets
MedIndia, India
Sat, 06/11/11 - 02:36 pm
Tags:
Aurobindo, ramipril, generics
Aurobindo Pharma Mulls Spinning Off Units
WSJ Online
Tue, 05/10/11 - 10:10 am
Tags:
Aurobindo

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.